Novorapid Penfill (Insulin Aspart)

Insulin aspart, the active ingredient in Novorapid Penfill, is a rapid‑acting insulin analog presented as a pre‑filled pen for subcutaneous use. It controls blood glucose levels in people with diabetes mellitus. GNH USA supplies Novorapid Penfill as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Novorapid Penfill as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Novorapid Penfill is a rapid‑acting insulin analog that lowers blood glucose by acting on the insulin pathway.

- Type 1 diabetes mellitus: improves post‑prandial glucose control. - Type 2 diabetes mellitus: provides mealtime insulin coverage. - Gestational diabetes mellitus: assists in controlling post‑meal blood sugar levels. - Diabetic ketoacidosis (DKI  ???)   ...  ....  ....  ...  .... ... … … ...  … … … … ... … … ...  …  … ... … … -  …   ...  ...  ...  ....  … …  …  … … … … … … … -  ……  …  ...  ...